Contract manufacturing

We offer contract manufacturing capabilities leveraging the quality, reliability and flexibility of our manufacturing facilities. We operate 29 manufacturing plants across the US, Europe and the MENA region.

Leveraging our high-quality local manufacturing expertise.

For all business development enquiries contact:

US and Canada: usbusinessdevelopment@hikma.com

Europe: EUBusinessDevelopment@hikma.com

MENA:
MENABusinessDevelopment@hikma.com

We offer a broad range of capabilities for oral, nasal and injectable products.

 Injectables 

Dosage forms

    Generics 

Dosage forms

Prefilled syringe

Tablets

IV bags

Capsules

Lyophilised

Nasals

Large parenteral

Oral solutions

Small parenteral

 

Specialised products

Specialised products

Cytotoxic/high containment

High containment

Emulsion

Respiratory

Cephalosporins

Controlled substances

Controlled substances

 

Generics

World class contract manufacturing in Columbus, OH, US
You can call us on 614-308-3500

Injectables

Advanced sterile injectable manufacturing operations in the US and Europe

New

Hikma Pharmaceuticals reaffirms commitment to expanding access to overdose-reversal medicine naloxone at White House mee...

Press Release, Corporate 06 June 2024
New

Hikma opens new UK office to support NHS supply, strengthening European presence

Press Release, Corporate 03 June 2024

Hikma enters the Spanish generic injectables market, strengthening its European presence

Press Release, Corporate 20 May 2024

Hikma launches Midazolam Injection, USP, in a prefilled syringe in the US

Press Release, Corporate 08 May 2024

Bringing Better Health Within Reach: Hikma’s journey to become the Partner of choice in MENA

Insight, Corporate 29 April 2024

Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated

Press Release, Financial Results 25 April 2024

Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business

Press Release, Corporate 15 April 2024

Hikma’s Executive Vice Chairman and President of MENA Joins Rakuten Medical’s Board of Directors

Press Release, Corporate 07 March 2024

Hikma delivers strong 2023 performance and a positive outlook for 2024

Press Release, Financial Results 22 February 2024

Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility

Press Release, Corporate 21 February 2024
Related content

Explore more